Veterans Hearing Aid Improvement Act of 2026
- Sponsor
- Rep. Self, Keith [R-TX-3]
- Committees
- Veterans' Affairs Committee (primary)
- Last action
- Jun 5, 2026
Bottom line
This bill establishes a two-year VA demonstration project to assess the effectiveness and fiscal impact of covering over-the-counter hearing aids for eligible veterans, alongside a GAO study on broader hearing aid benefits.
What it actually does
This bill directs the Department of Veterans Affairs (VA) to establish a two-year demonstration project to evaluate the fiscal impact and effectiveness of covering FDA-cleared, over-the-counter (OTC) hearing aids for veterans with mild-to-moderate hearing loss. The project will compare OTC aids to professionally fitted prescription aids and require interim and final reports to Congress. Additionally, it mandates a Government Accountability Office (GAO) study on broader veterans' hearing aid benefits.
Proponents argue
Supporters argue this bill will expand access to affordable hearing solutions for veterans with mild-to-moderate hearing loss, potentially reducing wait times and costs associated with traditional prescription hearing aids. They believe it leverages recent FDA regulations to improve veteran care and evaluate cost-effectiveness through a structured demonstration project.
Opponents contend
Critics might express concerns about the quality of care, arguing that professionally fitted prescription hearing aids offer superior outcomes and personalized adjustments that OTC devices may not replicate. They might also worry about potential misdiagnosis or inadequate support for veterans using OTC options without direct audiologist oversight, even with an initial clinical evaluation.
The bill is concise and can be read quickly, allowing ample time for a thorough evaluation of its provisions.
Section 2(a)-(g)
VA Demonstration Project on Over-the-Counter Hearing Aid Coverage
This section directs the Secretary of Veterans Affairs to commence a two-year demonstration project within one year of the bill's enactment. The project will evaluate the fiscal impact and effectiveness of covering FDA-cleared, over-the-counter (OTC) hearing aids for veterans with mild-to-moderate hearing loss, similar to how prescription hearing aids are currently covered. Eligible veterans must be enrolled in VA healthcare, receive an audiologist's determination of medical necessity for an OTC aid without red flag conditions, and possess a mobile device for aid functionality. The project will operate at a minimum of two VA medical facilities, comparing OTC aids to audiologist-fitted prescription aids with equal participant allocation, and will involve consultation with stakeholder organizations.
Supporters argue
Supporters argue this project is a crucial step towards modernizing VA hearing care, making it more accessible and potentially cost-effective by exploring OTC options. They highlight the importance of the audiologist evaluation and the comparison groups to ensure quality and gather robust data.
Critics contend
Critics might argue that even with an initial audiologist evaluation, relying on OTC devices could lead to less effective treatment or missed opportunities for comprehensive audiological care that prescription aids and ongoing professional support provide. They may also question the feasibility of ensuring mobile device access for all eligible veterans.
Tradeoffs
The bill balances the desire to expand access and potentially reduce costs with the need to maintain quality of care and ensure appropriate medical oversight. It also navigates the tension between traditional, professionally-fitted solutions and newer, more accessible OTC technologies.
Section 2(h)
Interim and Final Reports to Congress
This provision mandates two reports from the Secretary of Veterans Affairs to the House and Senate Committees on Veterans' Affairs. An interim report is due one year after the project starts, detailing progress and preliminary findings. A final report is due 180 days after the project concludes, including an evaluation of the fiscal impact of permanent OTC hearing aid coverage and other findings/recommendations, after soliciting formal input from stakeholder organizations.
Section 3
GAO Study on Hearing Aid Benefits for Veterans
This section directs the Comptroller General of the United States (GAO) to conduct a study on the provision of hearing aids and related examinations for veterans with mild-to-moderate hearing loss under current law. The study must examine the number of individuals needing hearing aids, their medical coverage, and the effectiveness of that coverage. It may also include an examination of contract design for purchasing hearing aid devices. A report on this study, including recommendations for changes to VA programs and benefits, is due to Congress within 18 months of enactment.
Defines "FDA-cleared, over-the-counter hearing aid" as a device cleared and fully regulated by the FDA under specific sections of the Federal Food, Drug, and Cosmetic Act, and which contains features allowing personalization through technology, such as hearing tests, software, and smartphone applications.
Section 2(i)
Why it matters:Standard legislative practice to place definitions at the end of a section where the term is primarily used.
Case for: Supporters argue this precise definition ensures that only legitimate, regulated, and technologically advanced OTC devices are considered for the demonstration project, protecting veterans and ensuring the project's integrity.
Case against: Critics might argue that the specific technological requirements (e.g., smartphone apps) could inadvertently exclude certain OTC devices or veterans who lack access to such technology, potentially limiting the scope of the project.
Estimated impact: Ensures the demonstration project focuses on a specific class of OTC hearing aids, potentially influencing the types of devices veterans might access in the future.